Sensorion Announces Publication of Seliforant Phase 1 Study Data in the British Journal of Clinical Pharmacology. pdfRead

Sensorion to partner with Vestibular Disorders Association (VeDA) in sponsorship of Balance Awareness Week 2018 for vestibular disorders. pdfRead

Sensorion announces three poster presentations at the 55th Inner Ear Biology Workshop. pdfRead

Sensorion Receives European Authorization to Initiate SENS-401 Phase 2 Trial in Sudden Sensorineural Hearing Loss. pdfRead

Sensorion Initiates Safety Study of Seliforant Versus Meclizine In Evoked Vestibular Imbalance. pdfread

Pipeline

2018 08 Pipeline

Enregistrer

Patient center

Corporate presentation

Next events